Multiple ascending dose study of MEDI1341 in patients with Parkinson's Disease

Trial Identifier: D6340C00002
Takeda Pharmaceutical Company Ltd
Start Date:August 2020
Primary Completion Date: January 2022
Study Completion Date: January 2022
Condition: Neurological & Brain - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

US, MI Farmington Hills, MI, US, 48334
US, IL Chicago, IL, US, 60612
US, GA Atlanta, GA, US, 30331
US, CA Long Beach, CA, US, 90806
US, FL Hallandale Beach, FL, US, 33009
US, TX Houston, TX, US, 77058
US, WA Kirkland, WA, US, 98034
US, WA Spokane, WA, US, 99202
US, OR Portland, OR, US, 97239